SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
BörsenkürzelSINT
Name des UnternehmensSINTX Technologies Inc
IPO-datumFeb 11, 2014
CEOOlson (Eric K)
Anzahl der mitarbeiter20
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 11
Addresse1885 West 2100 Street
StadtSALT LAKE CITY
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl84119
Telefon18018393516
Websitehttps://sintx.com/
BörsenkürzelSINT
IPO-datumFeb 11, 2014
CEOOlson (Eric K)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten